Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Antiviral drug development for coronavirus disease 2019 (COVID-19) is occurring at an unprecedented pace, yet there are still limited therapeutic options for treating this disease. We hypothesized that combining drugs with independent mechanisms of action could result in synergy against SARS-CoV-2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobrowski, Tesia, Chen, Lu, Eastman, Richard T., Itkin, Zina, Shinn, Paul, Chen, Catherine Z., Guo, Hui, Zheng, Wei, Michael, Sam, Simeonov, Anton, Hall, Matthew D., Zakharov, Alexey V., Muratov, Eugene N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834738/
https://www.ncbi.nlm.nih.gov/pubmed/33333292
http://dx.doi.org/10.1016/j.ymthe.2020.12.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834738/
https://www.ncbi.nlm.nih.gov/pubmed/33333292
http://dx.doi.org/10.1016/j.ymthe.2020.12.016

Ejemplares similares